Prediction of the Acute or Late Radiation Toxicity Effects in Radiotherapy Patients Using Ex Vivo Induced Biodosimetric Markers: A Review

by Volodymyr Vinnikov, Manoor Prakash Hande, Ruth Wilkins, Andrzej Wojcik, Eduardo Zubizarreta, Oleg Belyakov
Published 2020-12-01

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience

by Jure Murgic, Blanka Jaksic, Marin Prpic, Davor Kust, Amit Bahl, Mirjana Budanec, Angela Prgomet Secan, Pierfrancesco Franco, Ivan Kruljac, Borislav Spajic, Nenad Babic, Bozo Kruslin, Mario Zovak, Eduardo Zubizarreta, Eduardo Rosenblatt, Ana Fröbe
Published 2021-05-01

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

by Alexandre Arthur Jacinto, Eronides Salustiano Batalha Filho, Luciano de Souza Viana, Pedro De Marchi, Renato de Castro Capuzzo, Ricardo Ribeiro Gama, Domingos Boldrini Junior, Carlos Roberto Santos, Gustavo Dix Junqueira Pinto, Josiane Mourão Dias, Heloisa Pelisser Canton, Raiany Carvalho, Lucas Augusto Radicchi, Soren Bentzen, Eduardo Zubizarreta, Andre Lopes Carvalho
Published 2018-10-01

Prospective Assessment of the Association Between Circulating Tumor Cells and Control of Brain Disease After Focal Radiation Therapy of Breast Cancer Brain Metastases

by Douglas Guedes de Castro, MD, MSc, PhD, Alexcia Camila Braun, MSc, Vinicius Fernando Calsavara, PhD, Guilherme Rocha Melo Gondim, MD, Maria Letícia Gobo Silva, MD, MSc, Michael Jenwei Chen, MD, Ricardo Cesar Fogaroli, MD, MSc, Henderson Ramos, MD, Tharcisio Machado Coelho, MD, Ana Carolina Scintini Herbst, BSN, Emne Ali Abdallah, MSc, PhD, Liao Shin Yu, MD, MSc, Elena Fidarova, MD, MSc, Eduardo Zubizarreta, MD, Antônio Cássio Assis Pellizzon, MD, MSc, PhD, Ludmilla Thomé Domingos Chinen, MSc, PhD
Published 2021-03-01